Biogen Inc.

NASDAQ:BIIB

201.44 (USD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997199619951994199319921991199019891988198719861985
Revenue 9,835.610,173.410,981.713,444.614,377.913,452.912,273.911,448.810,763.89,703.3246,932.1995,516.4615,048.6344,716.4234,377.3484,097.5073,171.6171,872.1851,713.6191,595.819679.1831,148.3641,043.36926.452794.435557.587434.044277.09151.691156.344136.4123.761.450.128.520.68.66.415.1
Cost of Revenue 2,533.42,278.32,109.71,805.21,955.41,816.31,6301,478.71,240.41,171.036857.726545.494466.78400.262382.104401.989335.192274.383373.614554.319284.739160.159136.51125.198111.00574.50950.18828.52510.5049.9485.52.243.335.425.221.12123.34.5
Gross Profit 7,302.27,895.18,87211,639.412,422.511,636.610,643.99,970.19,523.48,532.2886,074.4734,970.9674,581.8544,316.1613,995.2443,695.5182,836.4251,597.8021,340.0051,041.5394.444988.205906.85801.254683.43483.078383.856248.565141.187146.396130.9121.518.114.73.3-0.5-12.4-16.910.6
Gross Profit Ratio 0.7420.7760.8080.8660.8640.8650.8670.8710.8850.8790.8760.9010.9080.9150.9130.9020.8940.8530.7820.6530.5810.8610.8690.8650.860.8660.8840.8970.9310.9360.960.9820.2950.2930.116-0.024-1.442-2.6410.702
Reseach & Development Expenses 2,4622,231.12,501.23,990.92,280.62,597.22,253.61,973.32,012.81,893.4221,444.0531,334.9191,219.6021,248.6041,283.0681,072.058925.1641,048.91747.671687.6631,056.337367.567314.556302.84221.153177.228145.501132.38487.44891.213000000000
General & Administrative Expenses 2,478.32,349.52,575.62,392.72,295.52,016.11,860.31,841.62,004.52,139.4421,639.3511,223.165000000000000000000000000000
Selling & Marketing Expenses 71.454.198.7111.879.290.275.2106.3108.692.972.754.3000000000000000000000000000
SG&A 2,549.72,403.62,674.32,504.52,374.72,106.31,935.51,947.92,113.12,232.3421,712.0511,277.4651,373.9041,289.6111,126.938925.305776.103685.067644.758578.487174.596324.001232.096170.058146.026115.21190.09873.63240.29324.686102.585.814.310.198.388.139
Other Expenses -3.5358.5888.5697.7731.511-215.4-217.4-123.7-25.781-34.93-0.744244.631208.928289.811459.544271.574257.316302.305347.67733.1800000-0.7111.726.00132.4046.77.15.13.83.33.13.84.14.5
Operating Expenses 5,471.14,993.26,0647,193.15,386.85,635.85,116.14,3174,508.54,615.5253,584.4093,132.4832,838.1372,747.1432,699.8172,456.9071,972.8411,991.2931,694.7341,613.8271,264.113691.568546.652472.898367.179292.439234.888207.736133.742148.303109.292.919.413.912.311.411.812.243.5
Operating Income 1,296.82,320.22,840.74,550.17,042.65,888.65,344.25,150.44,8913,972.4142,515.5091,855.8491,724.6911,248.8891,295.4271,213.611779.772440.02236.0443.416-869.669296.637360.198328.356316.251190.639148.96840.8297.445-1.90721.728.6-1.30.8-9-11.9-24.2-29.1-32.9
Operating Income Ratio 0.1320.2280.2590.3380.490.4380.4350.450.4540.4090.3630.3360.3420.2650.2960.2960.2460.2350.1380.027-1.280.2580.3450.3540.3980.3420.3430.1470.049-0.0120.1590.231-0.0210.016-0.316-0.578-2.814-4.547-2.179
Total Other Income Expenses Net -563.91,271.6-1,095.5497.483.3-101.2-399-720.1-247.629.87-9.48516.621-32.503-325.31224.552-174.468-16.089785.306557.82598.093-29.383-57.71329.299158.74912.76519.554000012.911.48.77.212.4111.81.35.3
Income Before Tax 1,296.83,591.81,745.25,047.57,125.95,899.65,128.84,9334,767.33,946.6332,480.5791,855.1051,711.2141,229.9061,332.6791,148.943910.595492.163256.19564.093-880.624276.595389.497487.105329.016210.193148.96840.8297.445-1.90734.639.97.583.4-0.9-22.4-27.8-18.7
Income Before Tax Ratio 0.1320.3530.1590.3750.4960.4390.4180.4310.4430.4070.3580.3360.3390.2610.3040.280.2870.2630.150.04-1.2970.2410.3730.5260.4140.3770.3430.1470.049-0.0120.2540.3230.1220.160.119-0.044-2.605-4.344-1.238
Income Tax Expense 135.3632.852.5992.31,1581,425.62,458.71,237.31,161.6989.942601.014470.554444.528331.333355.617365.776272.423278.43195.48439.007-5.52777.447116.814153.528108.56671.49659.8010.2991.7852.992.21.60.30.30.20.30.20.40.4
Net Income 1,161.13,046.91,556.14,000.65,888.54,430.72,539.13,702.83,5472,934.7841,862.3411,380.0331,234.4281,005.273970.132783.167638.172217.511160.71125.086-875.097199.148272.683333.577220.45138.69789.16740.535.66-4.89732.438.37.27.73.2-1.2-22.6-28.2-19.1
Net Income Ratio 0.1180.2990.1420.2980.410.3290.2070.3230.330.3020.2690.250.2450.2130.2220.1910.2010.1160.0940.016-1.2880.1730.2610.360.2770.2490.2050.1460.037-0.0310.2380.310.1170.1540.112-0.058-2.628-4.406-1.265
EPS 8.0220.9710.4424.8631.4721.6211.9416.9615.3812.427.865.85.093.983.372.672.020.640.480.07-4.920.971.840.750.490.310.20.0920.027-0.0250.0430.0470.0070.0030.002-0.003-0.043-0.06-0.043
EPS Diluted 7.9720.8710.424.831.4221.5811.9216.9315.3412.377.815.765.043.943.352.651.990.630.470.07-4.920.851.780.720.470.30.20.0920.027-0.0250.040.0450.0070.0030.002-0.003-0.043-0.06-0.043
EBITDA 2,598.92,686.13,656.64,807.37,518.76,860.36,526.16,541.45,521.44,350.8732,807.5672,023.3231,984.7861,945.4191,771.8881,837.471,347.477894.462819.111540.076-774.751382.954367.812208.431334.585195.675168.26456.09318.3616.14915.524.3-4.9-2.6-18.1-19.8-22.2-26.3-33.7
EBITDA Ratio 0.2640.2640.3330.3580.5230.510.5320.5710.5130.4480.4050.3670.3930.4120.4050.4480.4250.4780.4780.338-1.1410.3330.3530.2250.4210.3510.3880.2020.1210.0390.1140.196-0.08-0.052-0.635-0.961-2.581-4.109-2.232